James Paul Scopa, 10% Owner at Pacira Pharmaceuticals, Inc. (PCRX), bought 980,424 shares at $7.00 ($1.9M) on 2011-02-08, disclosed to the SEC on 2011-02-17.
Open-market purchase of $1.9M PCRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 712,567 | $0 | 0.0% |
| 2 | $7.00 | 267,857 | $1.9M | 100.0% |
| Total | $1.91 avg | 980,424 | $1.9M | 100% |
| Filing → |
| ADVM | SELL | 2021-11-17 | $218K | — | Filing → |
| DICE | BUY | 2021-09-16 | $102K | — | Filing → |
| ADVM | BUY | 2020-02-14 | $138K | — | Filing → |